CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
June 24, 2024 07:00 ET
|
CytoSorbents
Taiwan FDA approval of CytoSorb brings powerful blood purification therapy to critically ill and cardiac surgery patients in the country
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
June 13, 2024 07:00 ET
|
CytoSorbents
The launch of the PuriFi hemoperfusion machine is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification therapy
Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
February 27, 2024 08:30 ET
|
SeaStar Medical Holding Corporation
Interest continues to grow in developing new strategies to reduce systemic inflammation as a means of improving outcomes in heart failure patients DENVER, Feb. 27, 2024 (GLOBE NEWSWIRE)...
ICU Beds Global Market Report 2024: Strong Growth and Technological Advancements in Healthcare - Long-term Forecasts to 2028 and 2033
January 26, 2024 04:36 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "ICU Beds Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent ICU Beds Global Market Report for 2024...
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
October 30, 2023 08:00 ET
|
SeaStar Medical Holding Corporation
DENVER, Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated...
Rise in Chronic Health Conditions and Telehealth Services Propel Critical Care Diagnostics Market Growth
October 23, 2023 06:53 ET
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency...
CytoSorbents to Present at the 8th Annual Dawson James Conference
October 05, 2023 07:00 ET
|
CytoSorbents
CytoSorbents to Highlight Company Progress at Dawson James Small Cap Investor Growth Conference
Exploring Tele-ICU Market Opportunities: Global Market Expansion from 2023 to 2030
September 25, 2023 08:43 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Tele-Intensive Care Unit (ICU) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Tele-Intensive...
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
September 19, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
August 31, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...